Skip to content

William O. Adams

William Adams is an accomplished and experienced patent attorney, and his primary focus is patent litigation in the biotechnology, pharmaceutical, and medical device fields. William has been involved in numerous disputes on behalf of life sciences and pharmaceutical companies, and is co-chair of both the firm’s Hatch-Waxman and Life Sciences Litigation Practice Groups.

William has extensive experience in U.S. federal district courts regarding pharmaceutical patent litigation involving Abbreviated New Drug Applications under the Hatch-Waxman Act. Moreover, William has been involved in counseling clients under the Biologics Price Competition and Innovation Act (the “BPCIA”). William’s technical training (B.S. in Chemical Engineering & M.S. in Biotechnology), along with his previous experience working as a pharmaceutical development scientist at a leading drug delivery company allows him to quickly understand the technology at issue. William has had success on behalf of his clients in federal district courts, at the ITC, and at the USPTO.

Having spent time as in-house IP counsel, William truly understands the demands, perspectives, and budgets of his clients. That in-house experience has helped William ensure that each matter and case entrusted to him by his clients is handled efficiently and effectively.
University of Alabama, J.D., Editor of the Journal of the Legal Profession
Johns Hopkins University, M.S., Biotechnology
University of Alabama, B.S., Chemical Engineering
State Bar of California
U.S. Court of Appeals for the Federal Circuit
U.S. District Court – Central District of California
U.S. District Court – Northern District of California
U.S. District Court – Southern District of California
U.S. Patent and Trademark Office
Biotech

Aesthetic & Cosmetic Biotechnology

AgBio

Antibodies & Immunology

Biofuels

Biological Manufacturing of Chemicals

Biologics

Diagnostic Tools

Genomics

Industrial Enzymes

Peptides

Personalized Medicine

Stem Cells & Regenerative Medicine

Synthetic Biology & Nanotechnology

Therapeutics

Vaccines

Chemical, Industrial & Materials

Analytical Chemistry

Biochemistry

Chemical Engineering

Cosmetics & Personal Care Products

Food Chemistry

Fuel Cells & Batteries

Oil & Gas

Organic Chemistry

Pharmaceutical Chemistry

Physical Chemistry

Polymers

Consumer Products & Services

Aesthetics & Personal Care Products

Food & Beverage

Sporting Goods & Recreation

Energy

Biodegradable Materials

Bioenergy & Biofuels

Biomass

Clean Technology

Medical Devices & Procedures

Aesthetics & Implants

Biocompatible Polymers & Coatings

Cardiac Rhythm Management

Cardiovascular

Catheters & Probes

Dental Devices

Dermatology

Diagnostics

Drug-Eluting Devices

Embolic Protection

Minimally Invasive & Endoscopic Procedures

Oncology

Ophthalmology & Eye Care

Sleep Apnea

Pharmaceuticals

Antibodies and Immunology

Biological Manufacturing of Chemicals

Biologics

Biosimilars

Diagnostic Tools

Peptides

Personalized Medicine

Stem Cells & Regenerative Medicine

Therapeutics

Vaccines

Advertising, Media & Entertainment Practice
Antitrust & Competition
Appellate Litigation
Covered Business Method (CBM)
Due Diligence
Hatch-Waxman Litigation
Inter Partes Review (IPR)
International Trade Commission (ITC) Disputes
IP Strategy
IP Transactions, Agreements & Venture Capital
Litigation
Patent Litigation
Patent Trial & Appeal Board (PTAB) Trials (Post Grant)
Post-Grant Review (PGR)
Trade Secret
Trade Secret & Employee Mobility Litigation
Trade Secret & Employee Mobility Litigation
Trademark & Brand Protection
Trademark Litigation & Unfair Competition
Trademark Litigation & Unfair Competition
Trademark Trial & Appeal Board (TTAB) Disputes
TTAB Proceedings
Unfair Competition Litigation

  • Recognized by The Legal 500 “United States” for Patent Litigation (2024)
  • Recognized by The Legal 500 “United States” for Patent Litigation (2023)
  • American Chemical Society (ACS)
  • American Intellectual Property Law Association (AIPLA)
  • American Bar Association (ABA), Intellectual Property Section
  • Association of Business Trial Lawyers
By using this blog, you agree and understand that no information is being provided in the context of any attorney-client relationship. You further agree and understand that nothing herein is intended to be legal advice. This blog is solely informational in nature, and is not intended as, and should not be used as, a substitute for competent legal advice from a retained and licensed attorney in your state. Knobbe Martens LLP makes no representations or warranties as to the accuracy, completeness, timeliness or availability of the information in this blog. Knobbe Martens LLP will not be liable for any injury or damages relating to your use of, or access to, any such information. Knobbe Martens LLP undertakes no obligation to correct or update information on this blog, which may be incorrect or become incorrect or out of date over time. Knobbe Martens LLP reserves the right to alter or delete content or information on the blog at any time. This blog contains links and references to other websites and publications that you may find of interest. Knobbe Martens LLP does not control, promote, endorse or otherwise have any affiliation with any other websites or publications unless those websites or publications expressly state such an affiliation. Knobbe Martens LLP further has no responsibility for, and makes no representations regarding, the content, accuracy or any other aspect of the information in such websites or publications.
close modal